文献速递前列腺癌

多参数磁共振成像在前列腺穿刺活检前检测前列腺癌的诊断准确性

The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer.
PubMed 文献 · BJU Int · 2018-07-26

OBJECTIVES: To determine the extent to which clinically significant prostate cancer (csPCa) can be detected in a routine National Health Service setting in men with no previous biopsy, when multiparametric magnetic resonance imaging (mpMRI) is introduced into the diagnostic pathw…

要点

  • mpMRI的PI-RADS评分越高,csPCa检出率越高。
  • mpMRI诊断csPCa的敏感性82%、阴性预测值85%。
  • 正常mpMRI不能排除csPCa,可用于医患共同决策。

核心结论

  • 在常规临床环境中,未穿刺男性mpMRI的PI-RADS评分越高,csPCa检出率越高。
  • 正常mpMRI不能排除csPCa,但可辅助决定是否进行穿刺及后续治疗。

研究设计与样本

  • 以经会阴或经直肠超声引导穿刺活检为参考标准,csPCa定义为Gleason评分≥3+4。

主要发现

  • 经会阴和经直肠超声引导穿刺的中位针数分别为10针和6针。
  • csPCa总检出率为37%;PI-RADS 1和2中csPCa比例为15%,PI-RADS 5中为86%。
  • mpMRI诊断csPCa的敏感性82%、阴性预测值85%、特异性59%、阳性预测值54%。

关键数值与推荐

  • csPCa定义为Gleason评分≥3+4。
  • mpMRI诊断csPCa的敏感性82%、阴性预测值85%、特异性59%、阳性预测值54%。
  • PI-RADS 1和2中csPCa比例为15%,PI-RADS 5中为86%。

临床怎么用

  • 在未穿刺男性中,可根据mpMRI的PI-RADS评分评估csPCa风险。
  • mpMRI结果可用于医患共同决策是否进行穿刺活检。
  • 正常mpMRI不能排除csPCa,需结合临床综合判断。

局限性

  • 研究为回顾性设计。
  • 未报告漏诊癌症的随访数据。
  • mpMRI PI-RADS评分低的男性接受穿刺的可能性更低,这种选择偏倚可能高估csPCa检出率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the extent to which clinically significant prostate cancer (csPCa) can be detected in a routine National Health Service setting in men with no previous biopsy, when multiparametric magnetic resonance imaging (mpMRI) is introduced into the diagnostic pathway. PATIENTS AND METHODS: In all, 1 090 mpMRIs were performed between July 2013 and April 2016 in biopsy-naïve men with an abnormal prostate-specific antigen level and/or digital rectal examination. Data were collected from patient records at the Royal Devon and Exeter NHS Foundation Trust. mpMRI Prostate Imaging Reporting and Data System (PI-RADS) scores were compared to transperineal or transrectal ultrasonography (TRUS)-guided biopsy findings as the reference standard. csPCa was defined as Gleason score of ≥3+4. The diagnostic accuracy of mpMRI was also assessed. RESULTS: The mpMRI was interpretable in 1 023 men and 792 underwent biopsy, of which 106 were transperineal. The median number of cores taken in transperineal and TRUS-guided biopsy were 10 and 6, respectively. The detection rate of csPCa was 37%; csPCa rose from 15% of PI-RADS 1 and 2 to 86% of PI-RADS 5. The sensitivity, negative predictive value, specificity, and positive predictive value were 82%, 85%, 59% and 54%, respectively. The study is limited by its retrospective nature and lack of reporting of follow-up for 'missed cancers'. Men with low mpMRI PI-RADS were also less likely to undergo biopsy. Whilst this selection bias may overestimate the detection rate of csPCa, this reflects the shared decisions patients and clinicians make in day-to-day practice outside of research centres. CONCLUSION: In a routine clinical setting, the higher the mpMRI PI-RADS, the greater the detection rate of csPCa in biopsy-naïve men. A normal mpMRI does not exclude csPCa; however, mpMRI may have utility in informing shared-decision making on whether to proceed to biopsy and subsequent treatment.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Otti VC, Miller C, Powell RJ, et al. The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer. BJU Int. 2018. PMID: 29804315. doi:10.1111/bju.14420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。